Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125955051 | 12595505 | 1 | I | 20160719 | 20160727 | 20160727 | EXP | US-AMGEN-USASL2016094604 | AMGEN | 62.00 | YR | A | M | Y | 0.00000 | 20160726 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125955051 | 12595505 | 1 | PS | SENSIPAR | CINACALCET HYDROCHLORIDE | 1 | Oral | 30 MG, QD | 21688 | 30 | MG | TABLET | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125955051 | 12595505 | 1 | Hyperparathyroidism secondary |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125955051 | 12595505 | HO |
125955051 | 12595505 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125955051 | 12595505 | Internal haemorrhage | |
125955051 | 12595505 | Laboratory test abnormal |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |